Mackenzie Financial’s MaxCyte MXCT Stock Holding History

Mackenzie Financial’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$70K	Buy	+62,518	New	+$76.7K	﹤0.01%	1504

Other funds holding MXCT

Capricorn Fund Managers London, United Kingdom $1.06B AUM 45.98% 1-Year Est. Return

Peapod Lane Capital Bedford Hills, New York $134M AUM 63.91% 1-Year Est. Return

Brooklands Fund Management London, United Kingdom $782M AUM 0.49% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Willis Investment Counsel Gainesville, Georgia $1.97B AUM 25.29% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Cabot Wealth Management Salem, Massachusetts $999M AUM 14.8% 1-Year Est. Return

Granite Investment Partners El Segundo, California $1.84B AUM 35.93% 1-Year Est. Return

Mackenzie Financial's MXCT Position: Q3 2026 in Review

Mackenzie Financial opened a new position in MaxCyte (MXCT) in Q3 2026: 62,518 shares worth $70K. The stake represents ﹤0.01% of the portfolio and ranks #1504 among its holdings.

34 funds tracked by Wall St. Rank hold MXCT as of Q3 2026.

Mackenzie Financial held 62,518 shares of MaxCyte worth $70K as of Q3 2026.
MaxCyte was a new Mackenzie Financial position in Q3 2026.
MaxCyte made up ﹤0.01% of Mackenzie Financial's portfolio in Q3 2026, its #1504 holding.
34 funds tracked by Wall St. Rank held MaxCyte as of Q3 2026.

Based on Mackenzie Financial's 13F filing for Q3 2026, filed 2 Nov 2026.